Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,828 | -2,890 | -4,007 | -2,075 | -23,629 |
| Depreciation Amortization | 765 | 1,066 | 816 | 172 | 938 |
| Accounts receivable | 110 | -141 | 61 | -128 | N/A |
| Accounts payable and accrued liabilities | 109 | 1 | 23 | 188 | 68 |
| Other Working Capital | 1,338 | 40 | -325 | 496 | -463 |
| Other Operating Activity | 3,018 | 640 | 497 | 1,112 | 22,068 |
| Operating Cash Flow | $-487 | $-1,284 | $-2,934 | $-235 | $-1,018 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -1,465 | -582 | -171 |
| Purchase Of Investment | -675 | N/A | N/A | -35 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -130 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -130 | 0 | 0 |
| Investing Cash Flow | $-675 | $N/A | $-1,595 | $-617 | $-171 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 968 | 1,160 | 1,455 | N/A | N/A |
| Debt Repayment | -19 | -20 | -113 | N/A | -30 |
| Common Stock Issued | 348 | 130 | 2,782 | 1,098 | 1,380 |
| Financing Cash Flow | $1,297 | $1,270 | $4,124 | $1,098 | $1,350 |
| Beginning Cash Position | 1 | 15 | 420 | 173 | 12 |
| End Cash Position | 136 | 1 | 15 | 420 | 173 |
| Net Cash Flow | $135 | $-14 | $-405 | $247 | $161 |
| Free Cash Flow | |||||
| Operating Cash Flow | -487 | -1,284 | -2,934 | -235 | -1,018 |
| Capital Expenditure | N/A | N/A | -1,465 | -582 | -171 |
| Free Cash Flow | -487 | -1,284 | -4,399 | -816 | -1,189 |